
The app has benefitted from a complete redesign and redevelopment to provide clear visual learning for latching

This week we meet Hélène Guillaume, founder and CEO of the WILD.AI app

Second novel PCOS drug target from Celmatix-Evotec Alliance progresses into hit-identification

By Dr Pooja Sikka, venture partner at APEX Ventures

By Mridula Pore, co-CEO and co-founder of Peppy

FemCath is the first FDA-cleared intrauterine catheter that allows for selective evaluation of a fallopian tube with contrast, say developers

By Jyoti Sharma, Founder and CEO of TaraCares

By Jenny Saft, CEO and co-founder of Apryl

By Philippa Zorn, co-founder and co-CEO of HERMONE

The Paris-based company aims to improve access and quality of care for pregnant women and children